Brief: Dr Reddy's Exec Says Short Of Earlier Predicted Target, We Now Think We Can Sell 6 To 7 Million In Fiscal 2027

Dr. Reddy's Laboratories

09/07/2026 12:48

July 9 (Reuters) - Dr Reddy's Laboratories Ltd REDY.NS:
INDIA'S DR REDDY'S EXEC: WE GOT TO KNOW ABOUT THE ISSUE ON WEDNESDAY
DR REDDY'S EXEC: WE WILL BE ON TRACK TO SUPPLY BETWEEN 6-7 MILLION SEMAGLUTIDE PENS BETWEEN Q3 AND Q4
DR REDDY'S EXEC: ISSUE IS NOTHING TO DO WITH WHATEVER WE SENT TO MARKET
DR REDDY'S EXEC: ACTUAL SUPPLY TO MARKET CAN RESUME IN LATE OCTOBER TO EARLY NOVEMBER IF ISSUE RESOLVED
DR REDDY'S EXEC: THERE WILL BE HALT OF SUPPLY BETWEEN NOW AND SEPTEMBER
DR REDDY'S EXEC: NO QUESTION OF PRODUCT RECALL
DR REDDY'S EXEC: THERE WAS RECALL OF ONE BATCH IN INDIA, BUT IT HAS NOTHING TO DO WITH ISSUE
DR REDDY'S EXEC: WE MAY NEED TO WRITE DOWN SOME INVENTORY
DR REDDY'S EXEC: IMPURITY WAS IN API AND WAS DETECTED IN FORMULATION WHEN TESTED
DR REDDY'S EXEC: IMPURITY HAD TO DO WITH PROCESS, REACTION OF API; NO REQUIREMENT OF EQUIPMENT CHANGE
DR REDDY'S EXEC: THIS BATCH NEVER WENT INTO MARKET, NO PRODUCT RECALL, NEVER SHIPPED TO ANY MARKET
DR REDDY'S EXEC: NO SHORTAGE OF DEMAND, PRETTY CONFIDENT OF DEMAND
DR REDDY'S EXEC: SHORT OF EARLIER PREDICTED TARGET, WE NOW THINK WE CAN SELL 6 TO 7 MILLION IN FISCAL 2027
DR REDDY'S EXEC: WHEN WE GAVE EARLIER TARGET WE ASSUMED WE WOULD SELL BETWEEN JULY-SEPTEMBER, NOW UNLIKELY WE WILL DO THAT
Further company coverage: REDY.NS

 ((reuters.briefs@thomsonreuters.com;))